1. Gabbiani G, Ryan GB, Majno G. Presence of modified fibro-blasts in granulation tissue and their possible role in wound contraction. Experientia 1971 ;27:549-550. 2. Majno G, Gabbiani G, Hirschel B], et al. Contraction of granulation tissue in vitro: Similarity to smooth muscle. Sci-ence 1971;173:548-550. 3. Gabbiani G, Hirschel BJ, Ryan GB, et al. Granulation tissue as a contractile organ. A study of structure and function. ] Exp Med 1972;135:719-734. 4. Hirschel BJ, Gabbiani G, Ryan GB, et al. Fibroblasts of gran-ulation tissue: Immunofluorescent staining with antismooth muscle serum. Proc Soc Exp BioI Med 1971;138:466-469. 5. Gabbiani G, Ryan GB, Lamelin JP, et al. Human smooth muscle autoantibody. Its identification as antiactin anti-body and a study of its binding to "nonmuscular" cells. Am] Pathol 1973;72:473-488. 6. Seemayer TA, Lagace R, Schurch W, et al. The myofibro-blast: Biologic, pathologic, and theoretical considerations. PatholAnnu 1980;15:443-470. 7. Hinz B, Gabbiani G. Fibrosis: Recent advances in myofi-broblast biology and new therapeutic perspectives. F 1000 Biology Reports 2010;2:78-82. 8. Hinz B, Phan SH, Thannickal VJ, et al. The myofibroblast: One function, multiple origins. Am] Pathol 2007; 170: 1807-1816. 9. Majno G. The story of the myofibroblasts. Am] Surg Pathol 1979;3:535-542. 10. Majno G. The Healing Hand: Man and Wound in the Ancient World. Cambridge: Harvard University Press; 1975. 11. Carrel A, Hartmann A, Cicatrization of Wounds: 1.The Relation between the Size of a Wound and the Rate of Its Cicatrization.] Exp Med 1916;24:429-450. 12. Abercrombie M, Flint MH, James DW. Wound contraction in relation to collagen formation in scorbutic guinea pigs. ] Embryol Exp MorphoI1956;4:167-175. 13. Hoffmann-Berling H. Adenosinetriphosphate as the energy substance for cell movement. Biochim Biophys Acta 1954;14:182-194. 14. Majno G, Shea SM, Leventhal M. Endothelial contraction induced by histamine-type mediators: An electron micro-scopic study.] Cell BioI 1969;42:647-672. 15. Gabbiani G. Curr Contents: Citation Classics. 1988; 31: 16. 16. Gabbiani G, Majno G. Dupuytren's contracture: Fibroblast contraction? An ultrastructural study. Am ] Pathol 1972; 66: 131-146. 17. Ryan GB, Cliff WJ, Gabbiani G, et al. Myofibroblasts in human granulation tissue. Hum PathoI1974;5:55-67. 18. Gabbiani G, Chaponnier C, Huttner 1.Cytoplasmic fila-ments and gap junctions in epithelial cells and myofibro-blasts during wound healing. ] Cell BioI 1978;76:561-568. 19. Singer II, Kawka DW, Kazazis DM, et al. In vivo co-distribution of fibronectin and actin fibers in granulation tissue: Immunofluorescence and electron microscope stud-ies of the fibronexus at the myofibroblast surface.] Cell BioI 1984;98:2091-2106. 20. Tremblay G. Stromal aspects of breast carcinoma. Exp Mol Pathol 1979;31 :248-260. 21. Seemayer TA, Lagace R, Schurch W, et al. Myofibroblasts in the stroma of invasive and metastatic carcinoma: A possible host response to neoplasia. Am] Surg Pathol 1979;3:525-533. 22. Schurch W, Seemayer TA, Lagace R.Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study. Vir-chows Arch A PatholAnat HistoI1981;391:125-139.23. Schurch W, Lagace R, Seemayer TA. Myofibroblastic stro-mal reaction in retracted scirrhous carcinoma of the breast. Surg Gynecol Obstet 1982;154:351-358. 24. Skalli 0,Schurch W, Seemayer T, et al. Myofibroblasts from diverse pathologic settings are heterogeneous in their con-tent of actin isoforms and intermediate filament proteins. Lab Invest 1989;60:275-285. 25. Darby I, Skalli 0,Gabbiani G. Alpha-smooth muscle actin is transiently expressed by myofibroblasts during experimental wound healing. Lab Invest 1990;63:21-29. 26. Schurch W, Skalli 0, Gabbiani G. Cellular biology of Dupuytren's disease. In: McFarlane RM, McGrouther DA, Flint MH, eds. Dupuytren's Disease. London: Churchill Liv-ingstone; 1990:31-47. 27. Hinz B, Mastrangelo D, Iselin CE, et al. Mechanical tension controls granulation tissue contractile activity and myofibro-blast differentiation. Am] Pathol 2001; 159: 1009-1020. 28. Hinz B, Celetta G, Tomasek JJ,et al. Alpha-smooth muscle actin expression upregulates fibroblast contractile activity. Mol BioI Cell 2001;12:2730-2741. 29. Hinz B, Gabbiani G, Chaponnier C. The NH2-terminal peptide of alpha-smooth muscle actin inhibits force gen-eration by the myofibroblast in vitro and in vivo. ] Cell BioI 2002; 157:657-663. 30. Wang J, Zohar R, McCulloch CA. Multiple roles of alpha-smooth muscle actin in mechanotransduction. Exp Cell Res 2006;312:205-214. 31. Hinz B. The myofibroblast: Paradigm for a mechanically active cell.] Biomech 2010;43:146-155. 32. Goffin JM, Pittet P, Csucs G, et al. Focal adhesion size con-trols tension-dependent recruitment of alpha-smooth mus-cle actin to stress fibers.] Cell Biol 2006; 172:259-268. 33. Wipff PJ, Rifkin DB, Meister JJ,et al. Myofibroblast con-traction activates latent TGF-betal from the extracellular matrix.] Cell BioI 2007; 179: 1311-1323. 34. Arora PD, Narani N, McCulloch CA. The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am] Pathol 1999; 154:871-882. 35. Desmouliere A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1induces alpha-smooth muscle actin expres-sion in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts.] Cell BioI 1993;122:103-111. 36. Hennov-jessen L, Petersen OW. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993;68:696-707. 37. Zhang K, Rekhter MD, Gordon D, et al. Myofibroblasts and their role in lung collagen gene expression during pulmo-nary fibrosis. A combined immunohistochemical and in situ hybridization study. Am] Pathol 1994;145: 114-125. 38. Serini G, Bochaton-Piallat ML, Ropraz P, et al. The fibro-nectin domain ED-A is crucial for myofibroblastic pheno-type induction by transforming growth factor-betal. ] Cell BioI 1998; 142:873-881. 39. Desmouliere A, Redard M, Darby I, et al. Apoptosis medi-ates the decrease in cellularity during the transition between granulation tissue and scar. Am] PathoI1995;146:56-66. 40. Friedman SL. Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol HepatoI2004;1:98-105. 4l. Johnson R], lida H, Alpers CE, et al. Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation.] Clin Invest 1991;87:847-858. 42. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis.] Clin Invest 2003; 112: 1776-1784. 43. Yanez-Mo M, Lara-Pezzi E, Selgas R, et al. Peritoneal dialy-sis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl] Med 2003;348:403-413. 44. Bucala R, Spiegel LA, Chesney], et al. Circulating fibre-cytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1:71-8l. 45. Yang L, Scott PG, Giuffre], et al. Peripheral blood fibrocytes from burn patients: Identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Lab Invest 2002;82: 1183-1192. 46. Gabella G. Structural apparatus for force transmission in smooth muscles. Physiol Rev 1984;64:455-477. 47. Huttner I, Kocher 0,Gabbiani G. Endothelial and smooth muscle cells. In: Camilleri ]P, Berry CL, Fiessinger ]N, Bariety], eds. Diseases of the Arterial Wall. New York, NY: Springer-Verlag; 1989:3-4l. 48. Schollmeyer ]E, Furcht LT, Goll DE, et al. Localization of contractile proteins in smooth muscle cells and in nor-mal and transformed fibroblsts. In: Goldman R, Pollard T, Rosenbaum ], eds. Cell Motility. Cold Spring Harbor, NY: Cold Spring harbor Laboratory, 1976:361-388. 49. Medalia 0,Geiger B. Frontiers of microscopy-based research into cell-matrix adhesions. Curr Opin Cell Biol 2010;22: 659-668. 50. Hinz B, Gabbiani G. Cell-matrix and cell-cell contacts of myofibroblasts: Role in connective tissue remodeling. Thromb Haemost 2003;90:993-1002. 5l. Hinz B, Pittet P, Smith-Clerc ], et al. Myofibroblast devel-opment is characterized by specific cell-cell adherens junc-tions. Mol BioI Cell 2004;15:4310-4320. 52. Singer II. The fibronexus: A transmembrane association of fibronectin-containing fibers and bundles of 5 nm microfila-ments in hamster and human fibroblasts. Cell 1979;16:675-685. 53. Schurch W, Seemayer TA, Gabbiani G. The myofibroblast: A quarter century after its discovery. Am] Surg Patho11998; 22:141-147. 54. Eyden B. The fibronexus in reactive and tumoral myofibro-blasts: Further characterisation by electron microscopy. His-tol HistopathoI2001;16:57-70. 55. Weiss SW, Goldblum ]R, Enzinger FM. Fibrosarcoma. In: Weiss SW, Goldblum ]R, eds. Enzinger and Weisss Soft Tis-sue Tumors. St. Louis, MO: Mosby; 2001:416. 56. Erlandson RA. Role of Electron Microscopy in Modern Diagnostic Surgical Pathology. In: Weidner N, Cote R], Sus-ter S, Weiss LM, eds. Modern Surgical Pathology. Philadel-phia, PA: WB Saunders; 2003:83. 57. Rosai]. Rosai and Ackermans Surgical Pathology. St Louis, Missouri: Mosby; 2004. 58. Caplan AI, Fiszman MY, Eppenberger HM. Molecular and cell isoforms during development. Science 1983;221: 921-927. 59. Schurch W, Skalli 0,Seemayer TA, et al. Intermediate fila-ment proteins and actin isoforms as markers for soft tissuetumor differentiation and origin. I.Smooth muscle tumors. Am] PathoI1987;128:91-103. 60. Schurch W, Skalli 0,Lagace R, et al. Intermediate filament proteins and actin isoforms as markers for soft- tissue tumor differentiation and origin. III. Hemangiopericytomas and glomus tumors. Am] Pathol 1990;136:771-786. 6l. Babai F, Skalli 0,Schurch W, et al. Chemically induced rhabdomyosarcomas in rats. Ultrastructural, immunohis-tochemical, biochemical features and expression of alpha-actin isoforms. Virchows Arch BCell Pathol Incl Mol Pathol 1988;55:263-277. 62. Benzonana G, Skalli 0,Gabbiani G. Correlation between the distribution of smooth muscle or non muscle myosins and alpha-smooth muscle actin in normal and pathological soft tissues. Cell Motil Cytoskeleton 1988;11:260-274. 63. Larson OM, Fujiwara K, Alexander RW, et al. Myosin in cul-tured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression.] Cell BioI 1984;99: 1582-1589. 64. Gabbiani G, Schmid E, Winter S, et al. Vascular smooth muscle cells differ from other smooth muscle cells: predom-inance of vimentin filaments and a specific alpha-type actin. Proc NatlAcad Sci USA 1981;78:298-302. 65. Schmid E, Tapscott S, Bennett GS, et al. Differentialloca-tion of different types of intermediate-sized filaments in various tissues of the chicken embryo. Differentiation 1979; 15:27-40. 66. Lazarides E. Intermediate filaments as mechanical integra-tors of cellular space. Nature 1980;283:249-256. 67. Franke WW, Schmid E, Freudenstein C, et al. Intermediate-sized filaments of the prekeratin type in myoepithelial cells. ] Cell BioI 1980;84:633-654. 68. Vandekerckhove], Weber K.Actin typing on total cellular extracts: A highly sensitive protein-chemical procedure able to distinguish different actins. Eur] Biochem 1981 ;113: 595-603. 69. Chaponnier C, Gabbiani G. Pathological situations charac-terized by altered actin isoform expression. ] Pathol 2004; 204:386-395. 70. Hennessey ES, Drummond DR, Sparrow ]C, Molecular genetics of actin function. Biochem] 1993;291:657-67l. 71. Miwa T, Manabe Y, Kurokawa K, et al. Structure, chromo-some location, and expression of the human smooth muscle gamma-actin gene: Evolution of six human actin genes. Mol Cell BioI 1991; 11:3296-3306. 72. Tondeleir 0,Vandamme 0,Vandekerckhove ], et al. Actin isoform expression patterns during mammalian develop-ment and in pathology: Insights from mouse models. Cell Motil Cytoskeleton 2009;66:798-815. 73. Schurch W, Bochaton-Piallat ML, Geinoz A, et al. All histo-logical types of primary human rhabdomyosarcoma express alpha- cardiac and not alpha-skeletal actin messenger RNA. Am] Pathol 1994;144:836-846. 74. Dugina V,Zwaenepoel I, Gabbiani G, et al. Beta and gamma-cytoplasmic actins display distinct distribution and functional diversity.] Cell Sci 2009; 122:2980-2988. 75. Skalli 0,Bloom WS, Ropraz P, et al. Cytoskeletal remodel-ing of rat aortic smooth muscle cells in vitro: Relationships to culture conditions and analogies to in vivo situations. ] Submicrosc CytoI1986;18:481-493. 76. Skalli 0,Pelte MF, Peclet MC, et al. Alpha-smooth muscle actin, a differentiation marker of smooth muscle cells, is present in microfilamentous bundles of pericytes. ] Histo-chem Cytochem 1989;37:315-321. 77. Zimmermann KW. Der Feine Bau der Blutkapillaren. ZAnat Entwicklungsgesch 1923;68:29-109. 78. Nehls V,Drenckhahn D. Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. ] Cell BioI 1991;113:147-154. 79. Kapanci Y, Ribaux C, Chaponnier C, et al. Cytoskeletal features of alveolar myofibroblasts and pericytes in normal human and rat lung. ] Histochem Cytochem 1992;40: 1955-1963. 80. Tomasek JJ,Gabbiani G, Hinz B, et al. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell BioI 2002;3:349-363. 81. Chiavegato A, Bochaton-Piallat ML, D'Amore E, et al. Expression of myosin heavy chain isoforms in mammary epithelial cells and in myofibroblasts from different fibrotic settings during neoplasia. Virchows Arch 1995;426:77-86. 82. Malmstrom J, Lindberg H, Lindberg C, et al. Transforming growth factor-beta 1 specifically induce proteins involved in the myofibroblast contractile apparatus. Mol Cell Proteomics 2004;3:466-477. 83. Chambers RC, Leoni P, Kaminski N, et al. Global expres-sion profiling of fibroblast responses to transforming growth factor-beta 1 reveals the induction of inhibitor of differentiation-I and provides evidence of smooth muscle cell phenotypic switching. Am] Pathol 2003;162:533-546. 84. van der Loop FT, Gabbiani G, Kohnen G, et al. Differen-tiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromh Vasc BioI 1997; 17:665-671. 85. Christen T, Verin V,Bochaton-Piallat M, et al. Mechanisms of neointima formation and remodeling in the porcine coro-nary artery. Circulation 2001;103:882-888. 86. van der Loop FT, Schaart G, Timmer ED, et al. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. ] Cell BioI 1996; 134:40 1-411. 87. Loreal 0,Clement B, Deugnier Y.Hepatic fibrogenesis). Rev Prat 1997;47:482-486. 88. Hinz B. Formation and function of the myofibroblast during tissue repair.] Invest Dermatol 2007;127: 526-537. 89. Sommer P, Gleyzal C, Raccurt M, et al. Transient expression of lysyl oxidase by liver myofibroblasts in murine schistoso-miasis. Lab Invest 1993;69:460-470. 90. Volk SW, Wang Y, Mauldin EA, et al. Diminished type III collagen promotes myofibroblast differentiation and increases scar deposition in cutaneous wound healing. Cells Tissues Organs 2011; 194:25-37. 91. Lagace R, Grimaud JA, Schurch W, et al. Myofibroblastic stromal reaction in carcinoma of the breast: Variations of collagenous matrix and structural glycoproteins. Virchows Arch APathol Anat Histopathol 1985;408:49-59. 92. Barsky SH, Rao CN, Grotendorst GR, et al. Increased con-tent of Type V Collagen in desmoplasia of human breast car-cinoma. Am] PathoI1982;108:276-283. 93. Wessells NK, Spooner BS, Ash JF, et al. Microfilaments in cellular and developmental processes. Science 1971 ;171: 135-143.94. Madden Jw, Morton 0Jr, Peacock EE Jr. Contraction of experimental wounds. I.Inhibiting wound contraction by using a topical smooth muscle antagonist. Surgery 1974; 76:8-15. 95. Irle C, Kocher 0,Gabbiani G. Contractility of myofibro-blasts during experimental liver cirrhosis. Submicrosc Cytol PathoI1980;12:209-217. 96. Evans IN, Kelley J, Low RB, et al. Increased contractility of isolated lung parenchyma in an animal model of pul-monary fibrosis induced by bleomycin. Am Rev Respir Dis 1982; 125:89-94. 97. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-415. 98. Appleton I, Tomlinson A, Chander CL, et al. Effect of endothelin-I on croton oil-induced granulation tissue in the rat. A pharmacologic and immunohistochemical study. Lah Invest 1992;67:703-710. 99. Hahn AW, Resink TJ, Kern F, et al. Effects of endothelin-I on vascular smooth muscle cell phenotypic differentiation. ] Cardiovasc Pharmacol 1992;20:S33-S36. 100. Desmouliere A, Rubbia-Brandt L, Abdiu A, et al. Alpha-smooth muscle actin is expressed in a subpopulation of cul-tured and cloned fibroblasts and is modulated by gamma-interferon. Exp Cell Res 1992;201:64-73. 101. Vande Berg JS, Rudolph R, Woodward M. Comparative growth dynamics and morphology between cultured myofi-broblasts from granulating wounds and dermal fibroblasts. Am] PathoI1984;114:187-200. 102. Vande BergJS, Rudolph R, Poolman WL, et al. Comparative growth dynamics and actin concentration between cultured human myofibroblasts from granulating wounds and dermal fibroblasts from normal skin. Lab Invest 1989;61:532-538. 103. Germain L, Jean A, Auger FA, et al. Human wound healing fibroblasts have greater contractile properties than dermal fibroblasts.] Surg Res 1994;57:268-273. 104. Azzarone B, Failly-Crepin C, Daya-Crosjean L, et al. Abnor-mal behavior of cultured fibroblasts from nodule and non-affected aponeurosis of Dupuytren's disease. ] Cell Physiol 1983; 117 :353-361. 105. Dugina V,Alexandrova A, Chaponnier C, et al. Rat fibro-blasts cultured from various organs exhibit differences in alpha-smooth muscle actin expression, cytoskeletal pattern, and adhesive structure organization. Exp Cell Res 1998;238: 481-490. 106. Schmitt-Graff A, Desmouliere A, Gabbiani G. Heteroge-neity of myofibroblast phenotypic features: An example of fibroblastic cell plasticity. Virchows Arch 1994;425 :3-24. 107. Chang HY, Chi JT, Dudoit S, et al. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc NatlAcad Sci USA 2002;99:12877-12882. 108. Rinn JL, Bondre C, Gladstone HB, et al. Anatomic demar-cation by positional variation in fibroblast gene expression programs. PLoS Genet 2006;2:el19. 109. Schmitt-Graff A, Pau H, Spahr R, et al. Appearance of alpha-smooth muscle actin in human eye lens cells of ante-rior capsular cataract and in cultured bovine lens-forming cells. Differentiation 1990;43: 115-122. 110. Rennov-jessen L, van Deurs B, Celis JE, et al. Smooth mus-cle differentiation in cultured human breast gland stromal cells. Lab Invest 1990;63:532-543. Ill. Rockey DC, Friedman SL. Cytoskeleton of liver perisinusoi-dal cells in normal and pathological conditions. Cell Motil Cytoskeleton 1992;22:227-234. 112. Elger M, Drenckhahn D, Nobiling R, et al. Cultured rat mesangial cells contain smooth muscle alpha-actin not found in vivo. Am] Pathol 1993; 142:497-509. 113. Skalli 0,Ropraz P, Trzeciak A, et al. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.] Cell BioI 1986;103:2787-2796. 114. Isenberg G, Rathke PC, Hulsmann N, et al. Cytoplasmic actomyosin fibrils in tissue culture cells: Direct proof of contractility by visualization of ATP-induced contraction in fibrils isolated by laser micro-beam dissection. Cell Tissue Res 1976;166:427-443. 115. Kreis TE, Birchmeier W. Stress fiber sarcomeres of fibro-blasts are contractile. Cell 1980;22:555-561. 116. Hinz B. Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmis-sion. Eur] Cell BioI 2006;85: 175-181. 117. Chrzanowska Wodnicka M, Burridge K.Rho-stimulated contractility drives the formation of stress fibers and focal adhesions.] Cell BioI 1996;133:1403-1415. 118. Grinnell F, Petroll WM. Cell motility and mechanics in three-dimensional collagen matrices. Annu Rev Cell Dev BioI 2010;26:335-361. 119. Mochitate K, Pawelek P, Grinnell F.Stress relaxation of con-tracted collagen gels: Disruption of actin filament bundles, release of cell surface fibronectin, and down-regulation of DNA and protein synthesis. Exp Cell Res 1991;193: 198-207. 120. Werner S, Grose R.Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870. 121. Hinz B. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: Implications for the patho-genesis and treatment of fibrosis. Curr Rheumatol Rep 2009; 11:120-126. 122. Hinz B, Dugina V,Ballestrem C, et al. Alpha-smooth muscle actin Is crucial for focal adhesion maturation in myofibro-blasts. Mol BioI Cell 2003; 14:2508-2519. 123. Wipff PJ, Hinz B. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Eur] Cell BioI 2008;87:601-615. 124. Georges PC, Hui JJ,Gombos Z, et al. Increased stiffness of the rat liver precedes matrix deposition: Implications for fibrosis. Am] Physiol Gastrointest Liver Physiol 2007;293: Gl147-Gl154. 125. Barker HE, Chang J, Cox TR, et al. LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution. Cancer Res 2011;71:1561-1572. 126. Bogatkevich GS, Tourkina E, Abrams CS, et al. Contrac-tile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am] Physiol Lung Cell Mol Physiol 2003;285:L334-L343. 127. Shi-Wen X, Chen Y,Denton CP, et al. Endothelin-1 pro-motes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinaseIAkt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts. Mol BioI Cell 2004;15:2707-2719. 128. Rubbia-Brandt L, Sappino AP, Gabbiani G. Locally applied GM-CSF induces the accumulation of alpha-smooth mus-cle actin containing myofibroblasts. Virchows Arch BCell Pathol Incl Mol Pathol 1991 ;60:73-82.129. Kohan M, MuroAF, White ES, Berkman N. EDA-containing cellular fibronectin induces fibroblast differentiation through binding to alpha4beta7 integrin receptor and MAPKIErk 1/2-dependent signaling. FASEB] 2010;24:4503-4512. 130. Wells RG, Discher DE. Matrix Elasticity, Cytoskeletal Ten-sion, and TGF-~: The Insoluble and Soluble Meet. Sci Sig-nal2008; 1:pe13. 131. Micera A, Vigneti E, Pickholtz D, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibro-blasts, demonstrating a direct role for this factor in tissue repair. Proc NatlAcad Sci USA 2001;98:6162-6167. 132. Harris AK, Stopak D, Wild P.Fibroblast traction as a mecha-nism for collagen morphogenesis. Nature 1981 ;290:249-251. 133. Beningo KA, Wang YL. Flexible substrata for the detection of cellular traction forces. Trends Cell Biol 2002; 12:79-84. 134. Pfitzer G. Invited review: Regulation of myosin phosphoryla-tion in smooth muscle.] Appl PhysioI2001;91:497-503. 135. Katoh K, Kano Y,Amano M, et al. Rho-kinase-mediated con-traction of isolated stress fibers.] Cell Biol 2001;153:569-584. 136. Kimura K, Ito M, Amano M, et al. Regulation of myo-sin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996;273:245-248. 137. Somlyo AP, Somlyo AV. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325-1358. 138. Follonier Castella L, Gabbiani G, McCulloch CA. et al. Regulation of myofibroblast activities: Calcium pulls some strings behind the scene. Exp Cell Res 2010;316:2390-2401. 139. Tomasek JJ,Vaughan MB, Kropp BP, et al. Contraction of myofibroblasts in granulation tissue is dependent on Rhol Rho kinase/myosin light chain phosphatase activity. Wound Repair Regen 2006; 14:313-320. 140. Yee HF Jr, Melton AC, Tran BN. RhoNrho-associated kinase mediates fibroblast contractile force generation. Bio-chem. Biophys Res Commun 2001 ;280: 1340-1345. 141. Emmert DA, Fee JA, Goeckeler ZM, et al. Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts. Am] Physiol Cell Physiol 2004;286:C8-C21. 142. Nobe H, Nobe K, Fazal F, et al. Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation. Am] Physiol Cell Physiol 2003;284:C599-606. 143. Parizi M, Howard EW, Tomasek JJ.Regulation of LPA-promoted myofibroblast contraction: Role of Rho, myosin light chain kinase, and myosin light chain phosphatase. Exp Cell Res 2000;254:210-220. 144. Follonier Castella L, Buscemi L, Godbout C, et al. A new lock-step mechanism of matrix remodelling based on sub-cellular contractile events.] Cell Sci 2010; 123: 1751-1760. 145. Levinson H, Moyer KE, Saggers GC, et al. Calmodulin-myosin light chain kinase inhibition changes fibroblast-populated collagen lattice contraction, cell migration, focal adhesion formation, and wound contraction. Wound Repair Regen 2004;12:505-511. 146. Chilton L, Ohya S, Freed D, et al. K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am] Physiol Heart Circ PhysioI2005;288:H2931-H2939. 147. Raizman JE, Komljenovic J, Chang R, et al. The participa-tion of the Na+-Ca2+ exchanger in primary cardiac myo-fibroblast migration, contraction, and proliferation. ] Cell Physiol2007;213:540-551. 148. Kernochan LE, Tran BN, Tangkijvanich P, et al. Endothelin-l stimulates human colonic myofibroblast contraction and migration. Gut 2002;50:65-70. 149. Laleman W, Van Landeghem L, Severi T, et al. Both Ca2+ dependent and -independent pathways are involved in rat hepatic stellate cell contraction and intrahepatic hyper-responsiveness to methoxamine. Am] Physiol Gastrointest Liver Physiol 2007;292:G556-G564. 150. Kawada N, Tran-Thi TA, Klein H, et al. The contraction of hepatic stellate cells stimulated with vasoactive sub-stances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur] Bio-chem 1993;213:815-823. 151. Pinzani M, Failli P, Ruocco C, et al. Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intra-cellular calcium transients.] Clin Invest 1992;90:642-646. 152. Geiger B, Bershadsky A, Pankov R, et al. Transmembrane crosstalk between the extracellular matrix-cytoskeleton crosstalk. Nat Rev Mol Cell Biol2001;2:793-805. 153. Dugina V,Fontao L, Chaponnier C, et al. Focal adhesion features during myofibroblastic differentiation are con-trolled by intracellular and extracellular factors. ] Cell Sci 2001;114:3285-3296. 154. Cukierman E, Pankov R, Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002; 14:633-639. 155. Willingham M C, Yamada SS, Davies PJ, et al. Intracellu-lar localization of actin in cultured fibroblasts by electron microscopic immunocytochemistry. ] Histochem Cytochem 1981;29:17-37. 156. Ronnov-jessen L, Petersen OW. A function for filamentous alpha-smooth muscle actin: retardation of motility in fibro-blasts.] Cell Biol1996;134:67-80. 157. Pittet P, Lee K, Kulik AJ, et al. Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing indi-vidual OB-cadherin bonds.] Cell Sci 2008;121:877-886. 158. EI Sayegh TY,Kapus A, McCulloch CA. Beyond the epithe-lium: Cadherin function in fibrous connective tissues. FEBS Lett 2007;581: 167-174. 159. Tomita K, van BokhovenA, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-3654. 160. Shibata T, OchiaiA, Gotoh M, et al. Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. Cancer Lett 1996;99: 147-153. 161. Roosen A, Apostolidis A, Elneil S, et al. Cadherin-11 up-regulation in overactive bladder suburothelial myofibro-blasts.] Urol2009;182:190-195. 162. Follonier L, Schaub S, Meister JJ,et al. Myofibroblast com-munication is controlled by intercellular mechanical cou-pling.] Cell Sci 2008;121:3305-3316. 163. O'Shea JD. An ultrastructural study of smooth muscle-like cells in the theca externa of ovarian follicles in the rat. Anat Rec 1970; 167: 127-131. 164. Boya J, Carbonell AL, Martinez A. Myofibroblasts in human palatal mucosa. Acta Anat Basel 1988;131:161-165. 165. Guldner FH, Wolff JR, Keyserlingk DG. Fibroblasts as a part of the contractile system in duodenal villi of rat. Z Zell-forsch MikroskAnat 1972;135:349-360.166. Kaye GI, Lane N, Pascal RR. Colonic pericryptal fibroblast sheath: Replication, migration, and cytodifferentiation of a mesenchymal cell system in adult tissue. II. Fine structural aspects of normal rabbit and human colon. Gastroenterology 1968;54:852-865. 167. Bressler RS. Myoid cells in the capsule of the adrenal gland and in monolayers derived from cultured adrenal capsules. Anat Rec 1973;177:525-531. 168. Kapanci Y,AssimacopoulosA, Irle C, et al. "Contractile inter-stitial cells" in pulmonary alveolar septa: a possible regulator of ventilation-perfusion ratio? Ultrastructural, immunofluo-rescence, and in vitro studies.] Cell Biol1974;60:375-392. 169. Gorgas K, Bock P. Myofibroblasts in the rat testicular cap-sule. Cell Tissue Res 1974;154:533-541. 170. Czernobilsky B, Shezen E, Lifschitz-Mercer B, et al. Alpha smooth muscle actin in normal human ovaries, in ovarian stromal hyperplasia and in ovarian neo-plasms. VirchowsArch BCell Pathol lncl Mol Pathol1989;57: 55-61. 171. Parry EW. Some electron microscope observations on the mesenchymal structures of full-term umbilical cord. ] Anat 1970; 107: 505-518. 172. Tabone E, Andujar MB, De Barros SS, et al. Myofibroblast-like cells in non-pathological bovine endometrial caruncle. Cell Biol Int Rep 1983;7:395-400. 173. Beertsen W, Everts V,van den Hooff A. Fine structure of fibroblasts in the periodontal ligament of the rat incisor and their possible role in tooth eruption. Arch Oral Biol 1974; 19: 1087-1098. 174. Beertsen W. Migration of fibroblasts in the periodontalliga-ment of the mouse incisor as revealed by autoradiography. Arch Oral Biol 1975;20:659-666. 175. Toccanier-Pelte MF, Skalli 0,Kapanci Y, et al. Character-ization of stromal cells with myoid features in lymph nodes and spleen in normal and pathologic conditions. Am] Pathol 1987; 129: 109-118. 176. Yokoi Y, Namihisa T, Kuroda H, et al. Immunocytochemical detection of desmin in fat-storing cells. Hepatol-ogy 1984;4:709-714. 177. Glasser SR, Julian J.Intermediate filament protein as a marker of uterine stromal cell decidualization. Biol Reprod 1986;35:463-474. 178. Charbord P, Lerat H, Newton I, et al. The cytoskeleton of stromal cells from human bone marrow cultures resem-bles that of cultured smooth muscle cells. Exp Hematol 1990; 18:276-282. 179. Becker CG. Demonstration of actomyosin in mesangial cells of the renal glomerulus. Am] Pathol 1972;66:97-110. 180. Desmouliere A, Gabbiani G. Modulation of fibroblastic cytoskeletal features during pathological situations: the role of extracellular matrix and cytokines, Cell Motil. Cytoskel-eton 1994;29:195-203. 181. Sappino AP, Schurch W,Gabbiani G. Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as marker of phenotypic modulations. Lab Invest 1990;63: 144-161. 182. Eyden BP, Ponting ], Davies H, et al. Defining the myofibro-blast: Normal tissues, with special reference to the stromal cells of Wharton's jelly in human umbilical cord. ] Submi-crosc Cytol Pathol1994;26:347-355. 183. Rudolph R, Guber S, Suzuki M, et al. The life cycle of the myofibroblast. Surg Gynecol Obstet 1977;145:389-394. 184. Gabbiani G, Le Lous M, Bailey AJ, et al. Collagen and myofibroblasts of granulation tissue. A chemical, ultrastruc-tural and immunologic study. Virchows Arch BCell Pathol 1976;21 ;133-145. 185. Burrington JD. Wound healing in the fetal lamb.] Pediatr Surg 1971 ;6:523-528. 186. Rowsell AR. The intra-uterine healing of foetal muscle wounds: Experimentalstudyin the rat. Br] PlastSurg 1984;37: 635-642. 187. Adzick NS, Longaker MT. Scarless fetal healing. Therapeu-tic implications. Ann Surg 1992;215:3-7. 188. Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994; 56: 173-181. 189. Chakravarti S, Wu F, Vij N, et al. Microarray studies reveal macrophage-like function of stromal keratocytes in the cor-nea. Invest Ophthalmol Vis Sci 2004;45:3475-3484. 190. Pei Y,Sherry DM, McDermott AM. Thy-l distinguishes human corneal fibroblasts and myofibroblasts from kerato-cytes. Exp Eye Res 2004;79;705-712. 191. Seemayer TA, Schurch W, Lagace R. Myofibroblasts in human pathology. Hum Pathol1981;12:491-492. 192. Cassiman D, Libbrecht L, Desmet Y, et al. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers.] Hepatol 2002;36:200-209. 193. Rudolph R, McClure WJ, Woodward M. Contractile fibroblasts in chronic alcoholic cirrhosis. Gastroenterology 1979;76:704-709. 194. Madden JW. On "the contractile fibroblast". Plast Reconstr Surg 1973;52:291-292. 195. Woyke S, Domagala W, Olszewski W,et al. Pseudosarcoma of the skin. An electron microscopic study and comparison with the fine structure of spindle-cell variant of squamous carcinoma. Cancer 1974;33:970-980. 196. Larson DL, Abston S, Willis B, et al. Contracture and scar for-mation in the burn patient. Clin Plast Surg 1974;1:653-656. 197. Madden JW, Carlson EC, Hines J. Presence of modified fibroblasts in ischemic contracture of the intrinsic muscu-lature of the hand. Surg Gynecol Obstet 1975;140:509-516. 198. Nagle RB, Kneiser MR, Bulger RE, et al. Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy. Lab Invest 1973;29:422-427. 199. Judd PA, Finnegan P, Curran RC. Pulmonary sarcoidosis: A clinico-pathological study.] Pathol 1975; 115: 191-198. 200. EI-Labban NG, Lee KW. Myofibroblasts in central giant cell granuloma of the jaws: Anultrastructural study. Histopathol-ogy 1983;7:907-918. 201. Grimaud JA, Borojevic R. Myofibroblasts in hepatic schisto-somal fibrosis. Experientia 1977;33:890-892. 202. Postacchini F, Natali PG, Accinni L, et al. Contractile fila-ments in cells of regenerating tendon. Experientia 1977;33: 957-959. 203. Rudolph R, Abraham J, Vecchione T, et al. Myofibroblasts and free silicon around breast implants. Plast Reconstr Surg 1978;62: 185-196. 204. Callea F, Mebis J, Desmet VJ. Myofibroblasts in focal nodu-lar hyperplasia of the liver. Virchows Arch APathol Anat His-tol1982;396:155-166. 205. Ghadially FN, Mehta PN. Multifunctional mesenchymal cells resembling smooth muscle cells in ganglia of the wrist. Ann Rheum Dis 1971;30:31-42.206. Baur PS, Larson DL, Stacey TR. The observation of myofi-broblasts in hypertrophic scars. Surg Gynecol Obstet 1975; 141:22-26. 207. Novotny GE, Pau H. Myofibroblast-like cells in human anterior capsular cataract. Virchows Arch APathol Anat His-topathol1984;404:393-401. 208. Woodcock-Mitchell J,Adler KB,Low RB. Immunohistochem-ical identification of cell types in normal and in bleomycin-induced fibrotic rat lung. Cellular origins of interstitial cells. Am Rev Respir Dis 1984;130:910-916. 209. Lagace R, Delage C, Boutet M. Light and electron micro-scopic study of cellular proliferation in carcinoid heart disease. RecentAdv Stud Cardiac Struct Metab 1975;10:605-616. 210. Thomas WA, Jones R, Scott RF, et al. Production of early atherosclerotic lesions in rats characterized by prolifera-tion of "modified smooth muscle cells". Exp Mol Pathol 1963;52::40-61. 211. Flora G, Dahl E, Nelson E.Electron microscopic observa-tions on human intracranial arteries. Changes seen with aging and atherosclerosis. Arch Neurol1967;17:162-173. 212. Wissler RW. The arterial medial cell, smooth muscle, or multifunctional mesenchyme? Circulation 1967 ;36: 1-4. 213. Sappino AP, Masouye I, Saurat JH, et al. Smooth muscle differentiation in scleroderma fibroblastic cells. Am] Pathol 1990;137:585-591. 214. Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: Implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003;23: 1510-1520. 215. Hao H, Gabbiani G, Camenzind E, et al. Phenotypic mod-ulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol 2006;26:326-332. 216. Diamond JR, van Goor H, Ding G, et al. Myofibroblasts in experimental hydronephrosis. Am] Pathol 1995;146:121-129. 217. Desmouliere A, Gabbiani G. The role of myofibroblasts in wound healing and fibrocontractive diseases. In: Clark RAF, ed.The Molecular and Cellular Biology of Wound Repair. 2nd ed. New York, NY: Plenum Press; 1996:391-423. 218. Schurch W, Seemayer TA, Gabbiani G. Myofibroblasts. In: Sternberg SS, ed. Histology for Pathologists. New York, NY: Raven Press; 1992:109-144. 219. Ehrlich HP, Desmouliere A, Diegelmann RF, et al. Morpho-logical and immunochemical differences between keloid and hypertrophic scar. Am] PatholI994;145:105-113. 220. Gizycki MJ, Adelroth E, Rogers AY, et al. Myofibroblast involvement in the allergen-induced late response in mild atopic asthma. Am] Respir Cell Mol Biol1997; 16:664-673. 221. Santucci M, Borgognoni L, Reali UM, et al. Keloids and hypertrophic scars of Caucasians show distinctive mor-phologic and immunophenotypic profiles. Virchows Arch 2001;438:457-463. 222. Gabbrielli S, Di Lollo S, Stanflin N, et al. Myofibroblast and elastic and collagen fiber hyperplasia in the bronchial mucosa: a possible basis for the progressive irreversibility of airway obstruction in chronic asthma. Pathologica 1994;86: 157-160. 223. Hastie AT, Kraft WK, Nyce KB, et al. Asthmatic epithelial cell proliferation and stimulation of collagen production: human asthmatic epithelial cells stimulate collagen type III production by human lung myofibroblasts after segmental allergen challenge. Am] Respir Crit Care Med 2002;165: 266-272. 224. Bedi S, Vidyasagar A, Djamali A. Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis. Transplant Rev Orlando 2008;22:1-5. 225. KizuA, Medici D, Kalluri R.Endothelial-mesenchymal transi-tion as a novel mechanism for generating myofibroblasts during diabetic nephropathy. Am] PathoI 2009;175: 1371-1373. 226. Grgic I, Duffield JS, Humphreys BD. The origin of inter-stitial myofibroblasts in chronic kidney disease. Pediatr Nephrol 2011. 227. Li J, Deane JA, Campanale NY, et al. The contribution of bone marrow-derived cells to the development of renal inter-stitial fibrosis. Stem Cells 2007;25:697-706. 228. Bariety J. La biopsie renale dans la hyalinose segmentaire et focale des glomerules. In: Droz D, Lanz B. eds. La biopsie renale. Paris: Editions INSERM; 1996: 109-134. 229. Hills CE, Squires PE. TGF-betal-induced epithelial-to-mesenchymal transition and therapeutic intervention in dia-betic nephropathy. Am] Nephrol 2010;31:68-74. 230. Li J, Qu X, Bertram JF. Endothelial-myofibroblast transition contributes to the early development of diabetic renal inter-stitial fibrosis in streptozotocin-induced diabetic mice. Am] PathoI2009;175:1380-1388. 231. Enzinger FM, Weiss SW. Fibromatoses. In: Enzinger FM, Weiss SW, eds. Soft Tissue Tumors. St. Louis: Mosby; 1994:201-229. 232. Meister P, Gokel JM, Remberger K.Palmar fibromatosis-"Dupuytren's contracture". A comparison of light electron and immunofluorescence microscopic findings. Pathol Res Pract 1979;164:402-412. 233. Chiu HF, McFarlane RM. Pathogenesis of Dupuytren's con-tracture: A correlative clinical-pathological study. ] Hand SurgAm 1978;3:1-10. 234. Navas-Palacios Il-The fibromatoses. An ultrastructural study of 31 cases. Pathol Res Pract 1983;176:158-175. 235. Ushijima M, Tsuneyoshi M, Enjoji M. Dupuytren type fibromatoses. A clinicopathologic study of 62 cases. Acta Pathol]pn 1984;34:991-100l. 236. Allen PW. The fibromatoses: A clinicopathologic classifica-tion based on 140 cases. Am] Surg PatholI977;1:255-270. 237. Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer 1981 ;48: 1807-1818. 238. Wirman JA. Nodular fasciitis, a lesion of myofibroblasts: An ultrastructural study. Cancer 1976;38:2378-2389. 239. Chung EB, Enzinger FM. Proliferative fasciitis. Cancer 1975;36: 1450-1458. 240. Povysil C, Matejovsky Z. Ultrastructural evidence of myofi-broblasts in pseudomalignant myositis ossificans. Virchows Arch A PatholAnat HistolI979;381:189-203. 24l. Weathers DR, Campbell WG. Ultrastructure of the giant-cell fibroma of the oral mucosa. Oral Surg Oral Med Oral PatholI974;38:550-56l. 242. Stiller D, Katenkamp D. Cellular features in desmoid fibro-matosis and well-differentiated fibrosarcomas: An electron microscopic study. Virchows Arch A Pathol Anat Histol 1975;369: 155-164. 243. Ramos CY, Gillespie W, Narconis RJ. Elastofibroma. A pseudotumor of myofibroblasts. Arch Pathol Lab Med 1978; 102:538-540.244. Buell R, Wang NS, Seemayer TA, et al. Endobronchial plasma cell granuloma; a light and electron microscopic study. Hum Pathol 1976;7:411-426. 245. Bhawan J, Bacchetta C, Joris I, et al. A myofibroblastic tumor. Infantile digital fibroma (recurrent digital fibrous tumor of childhood). Am] Pathol 1979;94: 19-36. 246. Taxy JB. Juvenile nasopharyngeal angiofibroma: An ultra-structural study. Cancer 1977 ;39: 1044-1054. 247. Ferrans VJ, Roberts WC. Structural features of cardiac myx-omas. Histology, histochemistry; and electron microscopy. Hum PatholI973;4:111-146. 248. Fisher ER, Paulson JD, Gregorio RM. The myofibroblastic nature of the uterine plexiform tumor. Arch Pathol Lab Med 1978; 102:477-480. 249. 'Iomasek j],Schultz RJ, Episalla CW, et al. The cytoskeleton and extracellular matrix of the Dupuytren's disease "myofi-broblast": An immunofluorescence study of a nonmuscle cell type.] Hand Surg Am 1986; 11:365-3 7l. 250. Shum DT, McFarlane RM. Histogenesis of Dupuytren's dis-ease: An immunohistochemical study of 30 cases. ] Hand SurgAm 1988;13:61-67. 251. Schurch W, Begin LR, Seemayer TA, et al. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s. Am] Surg PathoI1996;20:131-147. 252. Luck JV Dupuytren's contracture; a new concept of the pathogenesis correlated with surgical management. ] Bone Joint SurgAm 1959;41A:635-664. 253. Iwasaki H, Muller H, Stutte HJ, et al. Palmar fibromatosis. Ultrastructural and enzyme his-tochemical studies of 43 cases. VirchowsArchA PatholAnat Histopathol 1984;405 :41-5 3. 254. Eddy RJ, Petro JA, Tomasek n.Evidence for the nonmus-cle nature of the "myofibroblast" of granulation tissue and hypertropic scar. Animmunofluorescence study. Am] Pathol 1988; 130:252-260. 255. Matte C, Cadotte M, Schurch W. Intermediate filament proteins and actin isoforms of dermatofibrosarcoma protu-berans and dermatofibroma. Lab Invest 1990;62:64A. 256. Fukasawa y,Ishikura H, Takada A, et al. Massive apopto-sis in infantile myofibromatosis. A putative mechanism of tumor regression. Am] PathoI1994;144:480-485. 257. Hinz B, Desmouliere A, Darby lA, et al. The role of the myofibroblast in fibrosis and cancer progression. In: Fusenig MMMN, ed. Tumor-Associated Fibroblasts and Their Matrix. Springer Dodrecht Heidelberg; 2011:37-74. 258. Desmouliere A, Darby lA, Gabbiani G. Normal and patho-logic soft tissue remodeling: Role of the myofibroblast, with special emphasis on liver and kidney fibrosis. Lab Invest 2003; 83: 1689-1707. 259. Cintorino M, Bellizzi de Marco E, Leoncini P, et al. Expres-sion of alpha-smooth-muscle actin in stromal cells of the uterine cervix during epithelial neoplastic changes. Int ] Cancer 1991;47:843-846. 260. Schurch W, Seemayer TA, Hinz B, et al. Myofibroblast. In: Mills SE ed. Histology for Pathologists. Philadelphia, PA: Lippincott-Williams &Wilkins Pub; 2007: 123-164. 261. Carroll R.The influence of lung scars on primary lung can-cer.] Pathol BacteriolI962;83:293-297. 262. Madri JA, Carter D. Scar cancers of the lung: origin and significance. Hum Pathol 1984; 15:625-63l. 263. Barsky SH, Huang SJ, Bhuta S. The extracellular matrix of pulmonary scar carcinomas is suggestive of a desmoplastic origin. Am] PathoI1986;124:412-419. 264. Micke P, Ostman A. Tumour-stroma interaction: Cancer-associated fibroblasts as novel targets in anti-cancer ther-apy? Lung Cancer 2004;45:SI63-175. 265. De Wever 0,Nguyen QD, Van Hoorde L, et al. Tenascin-C and SF/HGF produced by myofibroblasts in vitro provide convergent pro-invasive signals to human colon cancer cells through RhoA and Rac. Faseb] 2004;18:1016-1018. 266. Hill R, Song Y,Cardiff RD, et al. Selective evolution of stro-mal mesenchyme with p53 loss in response to epithelial tumorigenesis. Cell 2005; 123: 100 I-I 0 II. 267. Albini A, Sporn MB. The tumour microenvironment as a tar-get for chemoprevention. Nat Rev Cancer 2007;7:139-147. 268. Gonda TA, Varro A, Wang TC, et al. Molecular biology of cancer-associated fibroblasts: Can these cells be targeted in anti-cancer therapy? Semin Cell Dev BioI2009;21:2-10. 269. Lagace R, Schurch W, Seemayer TA. Myofibroblasts in soft tissue sarcomas. Virchows Arch APathol Anat Histol 1980;389: I-II. 270. Seemayer TA, Lagace R, Schurch W. On the pathogenesis of sclerosis and nodularity in nodular sclerosing Hodgkin's disease. Virchows Arch APathol Anat Histol 1980;385:283-291. 271. Taccagni G, Rovere E, Masullo M, et al. Myofibrosarcoma of the breast: Review of the literature on myofibroblastic tumors and criteria for defining myofibroblastic differentia-tion. Am] Surg Patho11997;21 :489-496. 272. Churg AM, Kahn LB. Myofibroblasts and related cells in malignant fibrous and fibrohistiocytic tumors. Hum Pathol 1977;8:205-218. 273. D'Andiran G, Gabbiani G. A metastasizing sarcoma of the pleura composed of myofibroblasts. In: Fenoglio CM, Woolf CM. eds. Progress in Surgical Pathology. New York, NY:Mas-son Publishing; 1980:31-40. 274. Eyden BP, Christensen L, Tagore V,et al. Myofibrosarcoma of subcutaneous soft tissue of the cheek.] Submicrosc Cytol Pathol 1992;24:307-313. 275. Mentzel T, Dry S, Katenkamp D, et al. Low-grade myofi-broblastic sarcoma: Analysis of 18 cases in the spectrum of myofibroblastic tumors. Am] Surg Pathol 1998;22:1228-1238. 276. Eyden BP, Banerjee SS, Harris M, et al. A study of spindle cell sarcomas showing myofibroblastic differentiation. Ultra-struct PatholI991;15:367-378. 277. Fisher C. Myofibroblastic malignancies. Adv Anat Pathol 2004;11: 190-201. 278. Alobeid B, Beneck D, Sreekantaiah C, et al. Congenital pul-monary myofibroblastic tumor: A case report with cytoge-netic analysis and review of the literature. Am] Surg Pathol 1997;21:610-614. 279. Fletcher CD, Tsang WY, Fisher C, et al. Angiomyofibroblas-toma of the vulva. A benign neoplasm distinct from aggres-sive angiomyxoma. Am] Surg PatholI992;16:373-382. 280. Fukunaga M, Nomura K, Matsumoto K, et al. Vulval angio-myofibroblastoma. Clinicopathologic analysis of six cases. Am] Clin PathoI1997;107:45-5I. 281. Ghadially FN, McNaughton JD, Lalonde JM. Myofibro-blastoma: A tumour of myofibroblasts. ] Submicrosc Cytol 1983; 15:1055-1063.282. Herrera GA, Johnson ww, Lockard VG, et al. Soft tissue myofibroblastomas. Mod PathoI1991;4:571-577. 283. Laskin WB, Fetsch JF, Mostofi FK. Angiomyofibroblastoma-like tumor of the male genital tract: analysis of II cases with comparison to female angiomyofibroblastoma and spindle cell lipoma. Am] Surg PathoI1998;22:6-16. 284. Ockner DM, Sayadi H, Swanson PE, et al. Genital angio-myofibroblastoma. Comparison with aggressive angiomyx-oma and other myxoid neoplasms of skin and soft tissue. Am ] Clin PathoI1997;107:36-44. 285. Prayson RA, Estes ML, McMahon JT, et al. Meningeal myo-fibroblastoma. Am] Surg Pathol 1993; 17:931-936. 286. Suster S, Rosai J. Intranodal hemorrhagic spindle-cell tumor with "amianthoid" fibers. Report of six cases of a distinctive mesenchymal neoplasm of the inguinal region that simu-lates Kaposi's sarcoma. Am] Surg PatholI989;13:347-357. 287. Thomas TM, MyintA, Mak CK, et al. Mammary myofibro-blastoma with leiomyomatous differentiation. Am ] Clin PatholI997;107:52-55. 288. Wargotz ES, Weiss SW, Norris HJ. Myofibroblastoma of the breast. Sixteen cases of a distinctive benign mesenchymal tumor. Am] Surg Pathol 1987; II :493-502. 289. Weiss SW, Gnepp DR, Bratthauer GL. Palisaded myofibro-blastoma. A benign mesenchymal tumor of lymph node. Am ] Surg PathoI1989;13:341-346. 290. Begin LR. Myogenic stromal tumor of the male breast (so-called myofibroblastoma). Ultrastruct Patho11991; 15:613-622. 291. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In: Fletcher CD, Unni KK, Mertens F, eds. Pathol-ogyand Genetics of Tumors of Soft Tissue and Bone. IARC, Lyon, France: World Health Organization Classification of Tumors; 2002:91-93. 292. O'Brien JE, Stout AP. Malignant Fibrous Xanthomas. Can-cer1964;17: 1445-1455. 293. Cessna MH, Zhou H, Sanger WG, et al. Expression of ALKI and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases. Mod Pathol 2002; 15:931-938. 294. Eyden B. Electron microscopy in the study of myofibroblas-tic lesions. Semin Diagn Pathol 2003;20: 13-24. 295. Cohnheim J. Ueber Entzundung und Eiterung. Virchows Arch path Anat 1867;40: 1-79. 296. Arey LG. Wound healing. Physiol Rev 1936;16:327-406. 297. Grillo HC. Derivation of fibroblasts in the healing wound. Arch Surg 1964;88:218-224. 298. Allgower M. The Cellular Basis of Wound Repair. Spring-field, IL: Oxford: Blackwell Scientific Publications; 1956. 299. Ross R, Everett NB, Tyler R. Wound healing and collagen formation. VI. The origin of the wound fibroblast studied in parabiosis.] Cell BioI 1970;44:645-654. 300. Oda D, Gown AM, Vande Berg JS, et al. The fibroblast-like nature of myofibroblasts. Exp Mol PathoI1988;49:316-329. 30 I. Hinz B. The myofibroblast in connective tissue repair and regeneration. In: Ralphs CAJ, ed. Regenerative Medicine and Biomaterials for the Repair of Connective Tissues. Cambridge: Woodhead Publishing Ltd; 2010:39-82. 302. Sundberg C, Ivarsson M, Gerdin B, et al. Pericytes as collagen-producing cells in excessive dermal scarring. Lab Invest 1996;74:452-466. 303. Rajkumar VS, Shiwen X, Bostrom M, et al. Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing. Am] Pathol2006;169:2254-2265. 304. Crocker OJ, Murad TM, Geer JC. Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol 1970; 13:51-65. 305. Wong JK, Lui YH, Kapacee Z, et al. The cellular biology of flexor tendon adhesion formation: An old problem in a new paradigm. Am] Pathol 2009;175: 1938-195l. 306. Kinner B, Gerstenfeld LC, Einhorn TA, et al. Expression of smooth muscle actin in connective tissue cells participating in fracture healing in a murine model. Bone 2002;30:738-745. 307. Spector M. Musculoskeletal connective tissue cells with muscle: Expression of muscle actin in and contraction of fibroblasts, chondrocytes, and osteoblasts. Wound Repair Regen 2001;9:11-18. 308. Kalluri R, Weinberg RA. The basics of epithelial-mesenchy-mal transition.] Clin Invest 2009;119:1420-1428. 309. Kim KK, Wei Y, Szekeres C, et al. Epithelial cell alpha3betal integrin links beta-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosis. ] Clin Invest 2009;119:213-224. 310. Ramadori G, Saile B. Portal tract fibrogenesis in the liver. Lab Invest 2004;84:153-159. 311. Desmouliere A. Hepatic stellate cells: the only cells involved in liver fibrogenesis? A dogma challenged. Gastroenterology 2007; 132:2059-2062. 312. Guyot C, Lepreux S, Combe C, et al. Hepatic fibrosis and cirrhosis: Thefibroblastic cell subpopulations involved. Int] Biochem Cell BioI 2006;38: 135-15l. 313. Herzog EL, Bucala R.Fibrocytes in health and disease. Exp Hematol20lO;38:548-556. 314. Wang 0,Park JS, Chu JS, et al. Proteomic profiling of bone marrow mesenchymal stem cells upon transforming growth factor betal stimulation.] BioI Chem 2004;279:43725--43734. 315. Gressner AM, Weiskirchen R.Modern pathogenetic con-cepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. ] Cell Mol Med 2006;10:76-99. 316. Moreels M, Vandenabeele F, Dumont 0,et al. Alpha-smooth muscle actin and nestin expression in reactive astrocytes in multiple sclerosis lesions: Potential regulatory role of transforming growth factor-beta 1 (TGF-betal). NeuropatholAppl Neurobiol2008;34:532-546. 317. Masszi A, Di Ciano C, Sirokmany G, et al. Central role for Rho in TGF-betal-induced alpha-smooth muscle actin expression during epithelial-mesenchymal transition. Am ] Physiol Renal PhysioI2003;284:F911-924. 318. Kocher 0,Skalli 0,Bloom WS, et al. Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experi-mental intimal thickening. Lab Invest 1984;50:645-652. 319. Charnley JH, Campbell GR, McConnell JD, et al. Com-parison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res 1977;177:503-522. 320. Moss NS, Benditt EP. Spontaneous and experimentally induced arterial lesions. I.An ultrastructural survey of the normal chicken aorta. Lab Invest 1970;22: 166-183. 32l. Mosse PR, Campbell GR, Wang ZL, et al. Smooth muscle phenotypic expression in human carotid arteries. I.Com-parison of cells from diffuse intimal thickenings adjacent toatheromatous plaques with those of the media. Lab Invest 1985;53:556-562. 322. Olivetti G, Anversa P, LoudAV Morphometric study of early postnatal development in the left and right ventricular myo-cardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ Res 1980;46:503-512. 323. Babai F, Musevi-Aghdam J, Schurch W, et al. Coexpression of alpha-sarcomeric actin, alpha-smooth muscle actin and desmin during myogenesis in rat and mouse embryos I.Skel-etal muscle, Differentiation 1990;44: 132-142. 324. Franke ww, Moll R.Cytoskeletal components of lymphoid organs. I.Synthesis of cytokeratins 8 and 18 and desmin in sub-populations of extrafollicular reticulum cells of human lymph nodes, tonsils, and spleen. Differentiation 1987;36:145-163. 325. Hormov-jessen L, Petersen Ow, Koteliansky VE, et al. The origin of the myofibroblasts in breast cancer. Recapitula-tion of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth mus-cle cells.] Clin Invest 1995;95:859-873. 326. Boukhalfa G, Desmouliere A, Rondeau E, et al. Relationship between alpha-smooth muscle actin expression and fibrotic changes in human kidney. Exp NephrolI996;4:241-247. 327. Vyalov SL, Gabbiani G, Kapanci Y.Rat alveolar myofibro-blasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am] Pathol 1993; 143: 1754-1765. 328. Thiery JP, Acloque H, Huang RY, et al. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-890. 329. Masszi A, Speight P, Charbonney E, et al. Fate-determining mechanisms in epithelial-myofibroblast transition: Major inhibitory role for Smad3.] Cell Biol20lO;188:383-399. 330. Humphreys BD, Lin SL, Kobayashi A, et al. Fate tracing reveals the pericyte and not epithelial origin of myofibro-blasts in kidney fibrosis. Am] Pathol2010;176:85-97. 33l. Ramadori G, Veit T, Schwogler S, et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing cells. Virchows Arch BCell Pathol Incl Mol PatholI990;59:349-357. 332. Schmitt-Graff A, Kruger S, Bochard F, et al. Modulation of alpha smooth muscle actin and desmin expression in peri-sinusoidal cells of normal and diseased human livers. Am] Pathol 1991; 138: 1233-1242. 333. Milani S, Herbst H, Schuppan 0,et al. Cellular localization of laminin gene transcripts in normal and fibrotic human liver. Am] PatholI989;134:1175-1182. 334. Milani S, Herbst H, Schuppan 0,et al. Cellular localization of type I III and IV procollagen gene transcripts in normal and fibrotic human liver. Am] PatholI990;137:59-70. 335. Rubbia-Brandt L, Mentha G, Desmouliere A, et al. Hepatic stellate cells reversibly express alpha-smooth muscle actin during acute hepatic ischemia. Transplant Proc 1997;29: 2390-2395. 336. Greenbaum LE, Wells RG. The role of stem cells in liver repair and fibrosis. Int] Biochem Cell Biol2011 ;43:222-229. 337. Forbes SJ, Russo FP, Rey V,et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 2004;126:955-963. 338. Kisseleva T, Uchinami H, Feirt N, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibre-sis.] Hepatol2006;45:429-438. 339. Mori L, Bellini A, Stacey MA, et al. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005;304:81-90. 340. Quan TE, Cowper SE, Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006;8: 145-150. 341. Schmidt M, Sun G, Stacey MA, et al. Identification of cir-culating fibrocytes as precursors of bronchial myofibroblasts in asthma.] Immunol2003;171:380-389. 342. Ishii G, Sangai T, Sugiyama K, et al. In vivo characterization of bone marrow-derived fibroblasts recruited into fibrotic lesions. Stem Cells 2005;23:699-706. 343. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibro-cytes traffic to the lungs in response to CXCL12 and medi-ate fibrosis.] Clin Invest 2004; 114:438-446. 344. Sakai N, Wada T, Yokoyama H, et al. Secondary lymphoid tissue chemokine/CCR 7 signaling regu-lates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 2006;103: 14098-14103. 345. Haudek SB, Xia Y, Huebener P, et al. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 2006; 103: 18284-18289. 346. Andersson-Sjoland A, de Alba CG, Nihlberg K, et al. Fibro-cytes are a potential source of lung fibroblasts in idiopathic pul-monary fibrosis. Int] Biochem Cell Biol 2008;40:2129-2140. 347. Wada T, Sakai N, Matsushima K, et al. Fibrocytes: A new insight into kidney fibrosis. Kidney Int 2007;72:269-273. 348. Frid MG, Brunetti JA, Burke DL, et al. Hypoxia-induced pulmonary vascular remodeling requires recruitment of circulating mesenchymal precursors of a monocyte/macro-phage lineage. Am] Pathol 2006;168:659-669. 349. Varcoe RL, Mikhail M, Guiffre AK, et al. The role of the fibrocyte in intimal hyperplasia. ] Thromh Haemost 2006; 4: 1125-1133. 350. Direkze NC, Hodivala-Dilke K, Jeffery R, et al. Bone mar-row contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 2004;64:8492-8495. 351. Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am] Respir Crit Care Med 2009; 179:588-594. 352. Wang CH, Huang CD, Lin HC, et al. Increased circulating fibrocytes in asthma with chronic airflow obstruction. Am] Respir Crit Care Med 2008;178:583-591. 353. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: Collagen deposition and wound repair. Stem Cells 2004;22:812-822. 354. Fujita J, Mori M, Kawada H, et al. Administration of granu-locyte colony-stimulating factor after myocardial infarc-tion enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007;25:2750-2759. 355. Schmitt-Graff A, Skalli 0,Gabbiani G. Alpha-smooth mus-cle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch B Cell Pathol Incl Mol PatholI989;57:291-302. 356. Yokota T, Kawakami Y, Nagai Y, et al. Bone marrow lacks a transplantable progenitor for smooth muscle type alpha-actin-expressing cells. Stem Cells 2006;24: 13-22. 357. Roufosse CA, Direkze NC, Otto WR, et al. Circulating mes-enchymal stem cells. Int] Biochem Cell BioI 2004;36:585-597.358. Skalli 0,Gabbiani G. The biology of the myofibroblast rela-tionship to wound contraction and fibrocontractive diseases. In: Clark RAF, Henson PM, eds. The Molecular and Cel-lular Biology of Wound Repair. New York,NY: Plenum Press; 1988:373-402. 359. Holgate ST, Davies DE, Lackie PM, et al. Epithelial-mesenchymal interactions in the pathogenesis of asthma. ] Allergy Clin Immunol 2000;105: 193-204. 360. Garbin S, Pittet B, Montandon D, et al. Covering by a flap induces apoptosis of granulation tissue myofibroblasts and vascular cells. Wound Repair Regen 1996;4:244-251. 361. Carlson MA, Longaker MT, Thompson JS. Granulation tis-sue regression induced by musculocutaneous advancement flap coverage. Surgery 2002;131:332-337. 362. Grinnell F, Zhu M, Carlson MA, et al. Release of mechanical tension triggers apoptosis of human fibroblasts in a model of regressing granulation tissue. Exp Cell Res 1999;248:608-619. 363. Douglass A, Wallace K, Parr R, et al. Antibody-targeted myo-fibroblast apoptosis reduces fibrosis during sustained liver injury.] Hepatol 2008;49:88-98. 364. Evans VG. Multiple pathways to apoptosis. Cell Biol Int 1993;17:461-476. 365. Lee S, Christakos S, Small MB. Apoptosis and signal trans-duction: Clues to a molecular mechanism. Curr Opin Cell Biol. 1993;5 :286-291. 366. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemis-try and molecular biology of programmed cell death. Endocr Rev 1993;14:133-151. 367. White E. Death-defying acts: A meeting review on apopto-sis.Genes Dev. 1993;7:2277-2284. 368. Williams GT, Smith CA. Molecular regulation of apoptosis: Genetic controls on cell death. Cell 1993;74:777-779. 369. Martin SJ, Green DR, Cotter TG. Dicing with death: Dis-secting the components of the apoptosis machinery. Trends Biochem Sci 1994; 19:26-30. 370. Evan GI, Wyllie AH, Gilbert CS, et al. Induction of apopto-sis in fibroblasts by c-myc protein. Cell 1992;69: 19-128. 371. Miura M, Zhu H, Rotello R, et al. Induction of apoptosis in fibroblasts by IL-l beta-converting enzyme, a mamma-lian homolog of the C. elegans cell death gene ced-3. Cell 1993;75:653-660. 372. Reed JC. Bel-2 and the regulation of programmed cell death. ] Cell BiolI994;124:1-6. 373. Horowitz JC, Rogers DS, Sharma V, et al. Combinatorial activation of FAK and AKT by transforming growth factor-betal confers an anoikis-resistant phenotype to myofibro-blasts. Cell Signal 2007;19:761-771. 374. de Andrade JA, Thannickal VJ.Innovative approaches to the therapy of fibrosis. Curr Opin Rheumatol2009;21:649-655. 375. Kulasekaran P, Scavone CA, Rogers DS, et al. Endothelin-l and transforming growth factor-beta 1 independently induce fibroblast resistance to apoptosis via AKT activation. Am] Respir Cell Mol Biol 2009;41 :484-493. 376. Laster SM, Wood JG, Gooding LR. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. ] ImmunolI988;14l:2629-2634. 377. Moulton BC. Transforming growth factor-beta stimu-lates endometrial stromal apoptosis in vitro. Endocrinology 1994; 134: 1055-1060. 378. Pierce GF, Mustoe TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth fac-tor and recombinant c-sis gene homodimeric proteins. ] Exp Med 1988;167:974-987. 379. Novo E, di Bonzo LV, Cannito S, et al. Hepatic myofibro-blasts: A heterogeneous population of multifunctional cells in liver fibrogenesis. IntJ Biochem Cell Biol 2009;41 :2089-2093. 380. Hecker L, Jagirdar R, Jin T, et al. Reversible differentiation of myofibroblasts by MyoD. Exp Cell Res 2011 ;317: 1914-1921. 381. Streuli CH, Schmidhauser C, Kobrin M, et al. Extracellular matrix regulates expression of the TGF-beta 1 gene. ] Cell BiolI993;120:253-260.382. Peyrol S, Raccourt F, Gerard F, Gleyzal C, Grimaud JA, Sommer P.Lysil oxidase gene expression in the stroma reac-tion to in situ and invasive ductal breast carcinoma. Am ] Pathol 1997; 150:497-507. 383. Doljanski F. The sculpturing role of fibroblast-like cells in morphogenesis. Perspect Biol Med 2004;47:339-356. 384. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-I/CXCLI2 secretion. Cell 2005;121:335-348. 385. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N EnglJ Med 1986;315:1650-1659.  